年會資訊

  1. 歐洲放射腫瘤年會 ESTRO 39, 03-07 April, 2020, Vienna, Austria
  2. PTCOG 59, May 9-14, 2020, Taipei, Taiwan
  3. 美國放射腫瘤年會 The 62th ASTRO Annual Meeting, 25-28 Oct, 2020, Miami Beach Convention Center, Miami Beach, Florida, USA.
 

研討會論文 

  1. W. H. Huang. et al. Radiation to Adrenal Gland Promotes Tumor Growth and Impairs Anti-PD-1 Efficacy (2019 ASTRO Oral Presentation) International Journal of Radiation Oncology • Biology • Physics , Volume 105 , Issue 1 , S123
  2. S. H. Liu. et al. Preventive Effect of Thixotropic Gel Containing Tea Tree Oil from Severe Radiation Dermatitis for Head and Neck Cancer Patients Receiving Chemoradiation (2019 ASTRO Poster) International Journal of Radiation Oncology • Biology • Physics , Volume 105 , Issue 1 , E377-E378
  3. Chen, Y.J. et al.Sequential Blockade of PD-1 and PD-L1 Causes Fulminant Cardiotoxicity – from Case Report to Mice Model Validation, (ESMO 2018 Poster) Annals of Oncology (2018) 29 (suppl_8): viii400-viii441. 10.1093/annonc/mdy288
  4. Dai, K.Y. et al. Risk-Based Optimization of Intensity-Modulated Radiation Therapy Guideline for Post-Operative Oral Cavity Cancer, (2018 ASTRO Poster) International Journal of Radiation Oncology • Biology • Physics , Volume 102 , Issue 3 , e237 - e238
  5. Chen, Y.S. et al. Mitomycin C Enhances Radiation Effect against Rectal Cancer with Favorable Modulation of Tumor Microenvironment, (2018 ASTRO Poster) International Journal of Radiation Oncology • Biology • Physics , Volume 102 , Issue 3 , e162
  6. Lee, J. et al. Image-Guided Study of Interfraction and Intrafraction Set-up Variability and Margins in Reverse Semi-Decubitus Breast Radiation Therapy, (2018 ASTRO Oral Presentation) International Journal of Radiation Oncology • Biology • Physics , Volume 102 , Issue 3 , S132
  7. Lee, J. et al. Skeletal Muscle Loss During Definitive Chemoradiotherapy is Negatively Associated with Outcomes in Locally Advanced Cervical Cancer, (2018 ASTRO Oral Presentation) International Journal of Radiation Oncology • Biology • Physics , Volume 102 , Issue 3 , S85

SCI論文發表

  1. Liu SY, Huang WC, Yeh HI, Ko CC, Shieh HR, Hung CL, Chen TY, Chen YJ*. Sequential Blockade of PD-1 and PD-L1 Causes Fulminant Cardiotoxicity-From Case Report to Mouse Model Validation. Cancers (Basel). 2019 Apr 24;11(4). pii: E580.
  2. Chen WK, Chen CA, Chi CW, Li LH, Lin CP, Shieh HR, Hsu ML, Ko CC, Hwang JJ, Chen YJ*. Moscatilin Inhibits Growth of Human Esophageal Cancer Xenograft and Sensitizes Cancer Cells to Radiotherapy. J Clin Med. 2019 Feb 5;8(2). pii: E187
  3. Su NW, Wu SH, Chi CW, Tsai TH, Chen YJ*. Cordycepin, isolated from medicinal fungus Cordyceps sinensis, enhances radiosensitivity of oral cancer associated with modulation of DNA damage repair. Food Chem Toxicol. 2019 Feb;124:400-410.
  4. Jie Lee*, J.B. Lin, M.H. Wu et al. Muscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancer. J Cachexia Sarcopenia Muscle. 2019 Aug;10(4):814-826.
  5. Jie Lee*, C.L. Chang, C.B. Lin, Skeletal Muscle Loss is an Imaging Biomarker of Outcome After Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer. Clin Cancer Res. 2018 Oct 15;24(20):5028-5036.
  6. Chang CW, Liu CY, Lee HC, Chen YJ*, Lactobacillus casei Variety rhamnosus Probiotic Preventively Attenuates 5-Fluorouracil/Oxaliplatin-Induced Intestinal Injury in a Syngeneic Colorectal Cancer Model. Front Microbiol. 2018 May 15;9:983.
  7. Liu YM, Liu YK, Huang PI, Tsai TH, Chen YJ*.Antrodia cinnamomea mycelial fermentation broth inhibits the epithelial-mesenchymal transition of human esophageal adenocarcinoma cancer cells. Food Chem Toxicol. 2018 Sep;119:380-386.
  8. Jie Lee*, M.H. Wu, Y.J Chen* et al.Impact of para-aortic recurrence risk-guided intensity-modulated radiotherapy in locally advanced cervical cancer with positive pelvic lymph nodes. Gynecol Oncol. 2018 Feb;148(2):291-98.
  9. Liu CK, Chen CA, Lee TY, Chang HH, Liao HF, Chen YJ*.Rice protein prolamin promotes anti-leukemia immunity and inhibits leukemia growth in vivo. Food Chem Toxicol. 2018 Feb;112:435-440.
  10. Jie Lee, M.H. Wu*, Y.J Chen* et al.Prophylactic lower para-aortic irradiation using intensity-modulated radiotherapy mitigates the risk of para-aortic recurrence in locally advanced cervical cancer: A 10-year institutional experience. Gynecol Oncol. 2017 Jul;146(1):20-26.
  11. Jie Lee, Y.J. Chen*, M.H. Wu, Development of delineation for the left anterior descending coronary artery region in left breast cancer radiotherapy: An optimized organ at risk. Radiother Oncol. 2017 Mar;122(3):423-430.
  12. Chen JC et al. Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse model. Oncotarget. 2016 Dec 20;7(51):85450-85463.
  13. Fu SL, Lin CC, Hsu ML, Liu SH, Huang YC, Chen YJ*. CCL-34, a synthetic toll-like receptor 4 activator, modulates differentiation and maturation of myeloid dendritic cells. OncoTarget. 2016 Feb.
  14. Lee J, Lin J-B, Sun F-J et al. Dosimetric predictors of acute haematological toxicity in oesophageal cancer patients treated with neoadjuvant chemoradiotherapy. The British journal of radiology. 2016;89:1066
  15. Chang CH, Liu SY, Chi CW, Yu HL, Chang TJ, Tsai TH, Lee TW, Chen YJ*. External beam radiotherapy synergizes 188Re-liposome against human esophageal cancer xenograft and modulates 188Re-liposome pharmacokinetics. Int J Nanomed. 2015 May; 10: 3641-3649. (IF= 4.383; Ranking: 11.76% (30/255) in Pharmacology & Pharmacy)
  16. Hui-Wen Lin, Shiyng Yu Lin, Wei Li Lin, Wei Zer Lin, Yuen-Liang Lai*. Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study. Lancet Oncology 2011;12(9):900-904.
  17. Liu SH, Chao KS, Leu YS, Lee JC, Liu CJ, Huang YC, Chang YF, Chen HW, Tsai JT, Chen YJ*. Guideline and preliminary clinical practice results for dose specification and target delineation for postoperative radiotherapy of oral cavity cancer. Head Neck-J Sci Spec. 2015 Jul; 37(7):933-939.